Practical aspects of standardization for a global control manufacturer Example: Enterovirus SoGAT XX Warsaw, Poland June 12, 2007 Ralf Schönbrunner, AcroMetrix.

Slides:



Advertisements
Similar presentations
Use of reference materials As Calibrators For metrological traceability As QC control To ensure international comparability –Only common reference point.
Advertisements

Nick Curry, MD, MPH Infectious Diseases Prevention Section
Development of a Panel for Dengue Virus Maria Rios, PhD CBER/FDA Blood Products Advisory Committee Meeting December 14, 2010.
Jean-Michel PAWLOTSKY
Comparing the New EIAs with Old Standbys: Florida Bureau of Laboratories Verification Data HIV Diagnostics: New Developments and Challenges Feb. 28, 2005.
REAL TIME PCR ………A step forward in medicine
Yi-Chen Yang, Drug Biology Division Bureau of Food and Drug Analysis Department of Health, Taiwan Collaborative study for establishment of the first national.
Paris, May 2004SoGAT XVII SoGAT and the Development of Standards Harvey Holmes Division of Retrovirology NIBSC, UK.
Karen Cristiano Biologicals Unit, CRIVIB Calibration against the WHO Standards of National Reference Preparations for detection of blood viruses by NAT:
Linearity Panels HIV RNA, HCV RNA, HBV DNA, and CMV DNA
XVIII SoGAT Washington 24 May 2005 SoGAT and HIV NAT Standards - 2 nd International Standard for HIV-1 RNA Harvey Holmes*, Clare Davis* and Alan Heath**
Viral Identification Using Microarray Introduction to Bioinformatics Dudu Burstein Current Subject.
THE DETECTION OF RICIN IN FOOD MATRICES USING ELISA TECHNOLOGY Eric A.E. Garber and Michael A. McLaughlin Division of Natural Products, Center for Food.
Applied Biosystems 7900HT Fast Real-Time PCR System I. Real-time RT-PCR analysis of siRNA-induced knockdown in mammalian cells (Amit Berson, Mor Hanan.
CBER's policies on assay regulation: Definitions of assay performance characteristics Andrew I. Dayton, M.D., Ph.D. CBER.
Converting BCR-ABL1 to the International Scale: Standardizing the Measurement of Relative Gene Expression Charles E. Hill Emory University School of Medicine.
SOURCE TRACKING AND MICROBIAL WATER QUALITY IN THREE FLORIDA SPRINGS Dale Griffin and Mike Gray USGS, St. Petersburg, FL.
Laboratory Investigation
An optimized DNA extraction and multiplex PCR for the detection of Fasciola sp. in lymnaeid snails. Reference: - Caron, Y., Rondelaud, D., Losson, B.,
FilmArray™ - Nested Multiplex PCR for Multi-pathogen Screening
COBAS AmpliPrep/Cobas TaqMan HIV-1 Test
BioLife Plasma Services Experience with HBV NAT Testing
Figure 2 depicts the positions of the primers and the probe in a multiple alignment of the 5´NTR of various enteroviruses. Moreover, the sensitivity of.
HIV, HCV, and HBV NAT Controls Formulation, Stability and Performance Mark Manak BBI Diagnostics, Inc. A Division of SeraCare Life Sciences, Inc. SoGAT.
CE MARKING OF IVDDs - the NIBSC perspective Morag Ferguson Division of Virology.
Approval Criteria for Assays for Testing Blood Donors for West Nile Virus Robin Biswas, M.D. CBER, FDA Blood Products Advisory Committee Meeting March.
NAT Standards for Clinical Virology Sally Baylis, NIBSC SoGAT XX, Warsaw June 2007.
Real-Time Quantitative PCR Basis
Stability of HCV, HIV-1 and HBV nucleic acids in plasma samples stored at different temperatures Marta José, Rodrigo Gajardo and Juan I. Jorquera Instituto.
Yi-Chen Yang, Yu-Hsuan Chen, Show-Lan Chiu, Hwei-Fang Cheng Drug Biology Division, Bureau of Food and Drug Analysis Department of Health, Taiwan, ROC National.
Quality Control Lecture 5
DNA contamination can often occur in quantitative reverse transcription – polymerase chain reactions (QRT-PCR), and should be removed in order to avoid.
SoGAT XVII/Paris, 2004 Proficiency Testing of In-House Developed HIV-1 NAT for Blood Screening Michael Chudy, Paul-Ehrlich-Institut Division of Virology,
HCV PCR By Henrietta Orji July 31 st, 2010 Hepatitis C Virus by Polymerase Chain Reaction.
Armored RNA Quant ™ Development of Armored RNA ® as a Primary Standard June 5, 2003 Cindy WalkerPeach, Ph.D. Director of Research and cGMP Operations Ambion.
SynTura: A New Ribonuclease Resistant Viral RNA Control Material Ralf Schönbrunner, Ph.D. SoGAT XXI Brussels, Belgium May 28, 2009.
LOWERING THE DETECTION LIMITS OF HIV-1 VIRAL LOAD USING REAL-TIME IMMUNO-PCR FOR HIV-1 P24 ANTIGEN Niel T. Constantine, Ph.D., Daniel Edelman, M.S., Janet.
Development of Standard Reagents for WNV NAT M. Rios, A. Grinev, K. Sirnivasan, O. Wood, S. Daniel, I. Hewlett CBER/FDA.
History of ILC Involvement in NAT Standardization 1998: Inter-Organization Discussion for the Establishment of Standard Reference Material for Nucleic.
Update on the P. falciparum Standard & Replacement of the HBV & HCV International Standards Sally Baylis, NIBSC SoGAT XIX.
A multi-centre NAT evaluation study of run and trend control samples Harry van Drimmelen 1, Joe O’Donnellan 2, Rene Bax 1, Henrik Ullum 3 and the Danish.
Molecular Testing and Clinical Diagnosis
Evaluation of the Presage™ ST2 ELISA Jun Lu 1, David G. Grenache 1,2 1 ARUP Institute for Clinical and Experimental Pathology, Salt Lake City, UT 2 Department.
Genetic differences between VZV wild-type and Oka strains Judith Breuer Professor of Virology St Barts and The London Hospital Medical School UK 1 Rome,
International Scientific Workshop on the Standardization of Genome Amplification Techniques for the Safety Testing of Blood, Tissues and Organs With Regard.
Bernd Haas 14 March 1958 – 4 October Replacement of FMDV cattle tongue titration by in-vitro titration Aldo Dekker.
An Overall View of Standardization May 26, 2004 Indira Hewlett, Ph.D. CBER/FDA.
Development and Characterization of Synthetic Standards: HCV RNA Susan E. Bromley, Ph.D. Director, Product Development Bayer Healthcare Diagnostics 24.
Confidential Extending the Armored RNA Technology to DNA Cindy WalkerPeach, Ph.D. Director, Development and Operations Ambion Diagnostics BSI EN ISO9001:2000.
 Routine viral diagnostics: indirect and direct detection of viruses. ◦ Indirect detection: serological tests; ◦ Direct detection:  Viral antigens;
Dengue fever caused by dengue virus (DENV), a member of Flaviviridae leads to large global disease burden. Detection of immunoglobulin M (IgM) and nucleic.
Date of download: 6/3/2016 From: Assessment of Hepatitis C Viremia Using Molecular Amplification Technologies: Correlations and Clinical Implications Ann.
SOGAT Presence (absence) of genotype 2 and 3 Erythrovirus DNA in manufacturing plasma Theo Cuypers, Marco Koppelman, Margret Sjerps, Henk Reesink.
INTRODUCTION & OBJECTIVES Introduction: The carcinogenesis of hepatocellular carcinoma (HCC) is a multifactorial, multistep and complex process. Its prognosis.
Dawit Assefa Ethiopia Health and Nutrition Research Institute Dawit Assefa Ethiopia Health and Nutrition Research Institute Evaluation of an in-house HIV.
Cepheid Symposium IAS 2017 Gwynn Stevens, PhD Director of Virology
Saeko Mizusawa, Yoshiaki Okada
IDEXX Laboratories, Water R&D. Westbrook, ME 04093
PREMARKET EVALUATION OF THE BD MAXTM CLOSTRIDIUM DIFFICILE PCE ASSAY
Clinical Validation of a New Triplex Real-Time Polymerase Chain Reaction Assay for the Detection and Discrimination of Herpes simplex Virus Types 1 and.
Harvey Holmes, Clare Morris and Neil Berry Division of Retrovirology
ASM 2017 Microbe Annual Meeting Sunday-507
Multiplex Detection of Ehrlichia and Anaplasma Species Pathogens in Peripheral Blood by Real-Time Reverse Transcriptase-Polymerase Chain Reaction  Kamesh.
Roche Molecular Diagnostics
Evaluation of Candidate Standard XX (97/650)
Clinical Validation of a New Triplex Real-Time Polymerase Chain Reaction Assay for the Detection and Discrimination of Herpes simplex Virus Types 1 and.
Feasibility of Synthetic Materials as Primary Standards
Real-Time Polymerase Chain Reaction Detection of Herpes Simplex Virus in Cerebrospinal Fluid and Cost Savings from Earlier Hospital Discharge  Kenneth.
STANDARDISATION, HARMONISATION AND TRACEABILITY
Human Papillomavirus Genotypes in Invasive Cervical Carcinoma in HIV-Seropositive and HIV-Seronegative Women in Zimbabwe.   Presenting author: Dr Alltalents.
Presentation transcript:

Practical aspects of standardization for a global control manufacturer Example: Enterovirus SoGAT XX Warsaw, Poland June 12, 2007 Ralf Schönbrunner, AcroMetrix

AcroMetrix’ Control Development AcroMetrix Quality System –ISO 13485:2003 certified –FDA 21CFR Part 820 Quality System Regulations (QSR) –cGMP –Calibrators and Controls values assigned following ISO 17511:2003 In vitro diagnostic medical devices —Measurement of quantities in biological samples — Metrological traceability of values assigned to calibrators and control materials

ISO 17511:2003 Five Metrological Levels Upper end of the metrological traceability chain –Level 1: Traceable to SI –Levels 2 – 5: Not traceable to SI See ISO 17511:2003 Introduction p. vii

Metrological Levels See ISO 17511:2003 Introduction p. vii

Metrological Level: 5 Requires In-house measurement procedure(s) In-house calibrator(s) –Example: Enterovirus, majority of viruses

Level 4: Calibration Hierarchy with International Standard WHO Standard

Level 5: Calibration Hierarchy without International Standard

Enteroviruses Metrological Level 5 Group: Group IV (+)ssRNA Family: Picornaviridae Genus: Enterovirus –No WHO Standard available

Genus enterovirus Human enterovirus A, B, C, D Bovine enterovirus Porcine enterovirus A, B Simian enterovirus Human rhinovirus A,B almost 100 different serotypes –Source: Fields Virology, 5 th edition, 2007 –Coxsackie viruses –Echovirus –Poliovirus

First EV Quantitation Zhang, HY, Yousef GE, Bowles NE, Archard LC, Mann GF, Mowbray JF J Med Virol Dec;26(4): Detection of enterovirus RNA in experimentally infected mice by molecular hybridisation: specificity of subgenomic probes in quantitative slot blot and in situ hybridisation. Department of Experimental Pathology, St. Mary's Hospital Medical School, London, England In situ-hybridization reportedly detected 10 to 100 enteroviral genomes

First EV PCR Quantitation T A Martino, M J Sole, L Z Penn, C C Liew, and P Liu J Clin Microbiol October; 31(10): 2634–2640. Quantitation of enteroviral RNA by competitive polymerase chain reaction. Center for Cardiovascular Research, Toronto Hospital, Ontario, Canada. Used competitive internal control standard Concentration measured at 260 nm Based on gels and radioactive [α- 32 P]dCTP quantitation Quantitation possible from 15 – 6000 TCID 50 Calibration Curve: [Standard] (pg) against CPM Std / CPM Virus

Cepheid Xpert EV assay FDA approval March 16, 2007 Reverse transcription polymerase chain reaction (RT-PCR) Qualitative detection of enterovirus (EV) RNA Cerebrospinal fluid (CSF) specimens Individuals with signs and symptoms of meningitis

EV Serotypes tested with Xpert EV Assay

Xpert EV LOD for 4 EV Genera representatives The LOD of the five (5) serotypes, one from each of the enterovirus species are shown in the table below. CVA6 (A), CVA9 (B), CVA17 (C), EV70 (D) and PV1 (C - poliovirus)

Challenges for Development of a Low PC useful for Xpert EV No international EV standard Which enterovirus should be used? Which unit should be used? What is correct level for control? –(about x LOD)

EV in-House working calibrator Step 1in ISO17511 to generate EV Low PC Which EV strain should be used? –Meningitis causing – see assay intended use –Defined LOD –CVA6 or CVA9 Which unit should be used? –Copies –Genome equivalents –IU –TCID 50 –pg RNA What is best level for in-house working calibrator? –Significantly higher than Low PC

Objective for in-house working calibrator Requirements: –Proxy for non existing International Standard –Same strain as Low Positive Control –Easily available stock material Not necessary to know: –Number of viruses in calibrator –Number of Signal Generating Units (SGU)

EV strain for in-House working calibrator Human Enterovirus Species B Type: Coxsackie A9 (CVA9) Strain: P.B. (Bozek) Geographic Origin: New York Illness yielding prototype virus: Meningitis Accession Number: D00627 Heat inactivated, 56ºC, 30 min –K.E. van Vliet et al. J.Clin.Microbiol. (2001) 39, p.3390

in-House working calibrator unit Copies – No. Avoid confusion with other people’s copies SGU – No. Dependent on assay sensitivity Genome equivalents – Ideally yes, but no general accepted reference measurement procedure available IU – Requires international protocol for value assignment by international scientific organization TCID 50 – Heat inactivated: TCID 50 = ∞ pg RNA – No accepted int. reference method Generated independent in-house unit –according ISO 17511:2003 clause d

Enterovirus Unit (EVU) Basis to deliver consistent control Not based on SI unit Arbitrarily defined unit –similar to WHO IU No claim about number of viruses Traceable or commutable to other units –Qiagen copies –Cepheid TCID 50 –Future WHO Standard?

In-house working calibrator level 500 times higher than Low Pos Control Low Pos Control about x LOD of Xpert EV –Target level of EV low PC: 100 EVU/mL In-house calibrator: EVU/mL –Named: EV APS (AcroMetrix Primary Standard) Product calibrator: 100 EVU/mL –Named: EV LPC AQS (AcroMetrix QC Standard)

EV in-house working calibrator & EV product calibrator development Obtained high titer stock CVA9 Determined dilution factor to 4xLOD Diluted 500 fold less to generate EV in-house working calibrator (EV APS) Defined EV APS at EVU/mL Diluted EV APS 1:500 to generate EV product calibrator (EV LPC AQS) Defined EV LPC AQS at 100 EVU/mL

OptiQual EV Low PC Heat inactivated CVA9 Level: 100 ± 30 EVU/mL Fill volume: 300 µL Storage: -70ºC –Goal: switch to -20ºC

Results with OptiQual EV LPC 2 independent labs

Possible Downsides Meaning of EVU? –No SI unit –Metrological based –Driven by ISO What’s an IU? Many different enteroviruses –CVA9 one of many enteroviruses –Similar to HIV subtypes and HCV genotypes –Consider naming it CVA9 unit?

Conclusions OptiQual EV control very reproducible results with geneXpert EV assay Level probably higher than 3 – 5 LOD –CV very low for 3 – 5 xLOD –labs use low CV of control to asses variability –evaluations ongoing –some other EV assays show high CV Adjustment to different level easily possible, due to availability of in-house calibrators

Proposal Quickly & proactively create “WHO Standards” for “orphan pathogens”* and *: Pathogens currently without International Standard Provide protocol for value assignment Act before commercial assays are available Unit: IU